| Jennifer Villwock, MD | |
|
3901 Rainbow Blvd, Mail Stop 3010, Kansas City, KS 66160-8500 | |
| (913) 588-8328 | |
| Not Available |
| Full Name | Jennifer Villwock |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 13 Years |
| Location | 3901 Rainbow Blvd, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073804902 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 04-38998 (Kansas) | Primary |
| 207Y00000X | Otolaryngology | 2016013812 (Missouri) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
News Archive
Just as we might have guessed, those tasty, sugar-sweetened beverages that increase risk of diabetes and other chronic diseases may actually be addictive.
Research published today in the Proceedings of the National Academy of Sciences demonstrates that technology invented by researchers at Oregon Health & Science University's Casey Eye Institute can improve the clinical management of the leading causes of blindness.
Researchers have developed a multiplex blood assay that may aid the identification of high-risk individuals who will progress to psychosis.
Genentech, a member of the Roche Group, today announced 24-month results from the two pivotal Phase III trials (RISE and RIDE) assessing the efficacy and safety of Lucentis (ranibizumab injection) in people with diabetic macular edema (DME).
On April 20, 2010, an explosion on the Deepwater Horizon oil rig triggered what would become the largest marine oil spill in history. Before the well was finally capped 87 days later on July 15, an estimated 4 million barrels of oil had gushed into the Gulf of Mexico, harming ecosystems, contaminating shorelines, and strangling the fishing and tourism industries.
› Verified 4 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
Just as we might have guessed, those tasty, sugar-sweetened beverages that increase risk of diabetes and other chronic diseases may actually be addictive.
Research published today in the Proceedings of the National Academy of Sciences demonstrates that technology invented by researchers at Oregon Health & Science University's Casey Eye Institute can improve the clinical management of the leading causes of blindness.
Researchers have developed a multiplex blood assay that may aid the identification of high-risk individuals who will progress to psychosis.
Genentech, a member of the Roche Group, today announced 24-month results from the two pivotal Phase III trials (RISE and RIDE) assessing the efficacy and safety of Lucentis (ranibizumab injection) in people with diabetic macular edema (DME).
On April 20, 2010, an explosion on the Deepwater Horizon oil rig triggered what would become the largest marine oil spill in history. Before the well was finally capped 87 days later on July 15, an estimated 4 million barrels of oil had gushed into the Gulf of Mexico, harming ecosystems, contaminating shorelines, and strangling the fishing and tourism industries.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Villwock, MD 3901 Rainbow Blvd, Mail Stop 3010, Kansas City, KS 66160-8500 Ph: (913) 588-8328 | Jennifer Villwock, MD 3901 Rainbow Blvd, Mail Stop 3010, Kansas City, KS 66160-8500 Ph: (913) 588-8328 |
News Archive
Just as we might have guessed, those tasty, sugar-sweetened beverages that increase risk of diabetes and other chronic diseases may actually be addictive.
Research published today in the Proceedings of the National Academy of Sciences demonstrates that technology invented by researchers at Oregon Health & Science University's Casey Eye Institute can improve the clinical management of the leading causes of blindness.
Researchers have developed a multiplex blood assay that may aid the identification of high-risk individuals who will progress to psychosis.
Genentech, a member of the Roche Group, today announced 24-month results from the two pivotal Phase III trials (RISE and RIDE) assessing the efficacy and safety of Lucentis (ranibizumab injection) in people with diabetic macular edema (DME).
On April 20, 2010, an explosion on the Deepwater Horizon oil rig triggered what would become the largest marine oil spill in history. Before the well was finally capped 87 days later on July 15, an estimated 4 million barrels of oil had gushed into the Gulf of Mexico, harming ecosystems, contaminating shorelines, and strangling the fishing and tourism industries.
› Verified 4 days ago
Dr. Terance T Tsue, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 3010, Kansas City, KS 66160 Phone: 913-588-6701 Fax: 913-588-6708 | |
Frantzlee Lacrete, MD/MPH Otolaryngology Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6739 | |
Christopher Jordan Boyd, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6739 | |
Dr. Gregory Alan Ator, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 3010, Kansas City, KS 66160 Phone: 913-588-6701 Fax: 913-588-6708 | |
Hannah Linnea Kavookjian, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd # Ms 3010, Kansas City, KS 66160 Phone: 913-574-9135 | |
Dr. Douglas A Girod, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 3010, Kansas City, KS 66160 Phone: 913-588-6701 Fax: 913-588-6708 |